CDKN2A and melanoma: The immunohistological characteristics of the latter were consistent with observations in other murine melanoma models, such as Tyr::CreERT2; tdTomatolox; Tyr::NrasQ61K; Cdkn2a−/−-derived skin tumors (Shakhova et al., 2012; Zingg et al., 2018) (Fig. S1A-F).